Effect of iodinated contrast media on blood clotting.
Recently, blood clot formation in catheters used for the injection of nonionic contrast media (CM) during angiography has been reported as being due to activation of hemostasis in the catheter. However, CM exhibit inhibitory properties regarding coagulation and platelet functions. The effect on blood clotting of iohexol, iopamidol, ioxaglate, diatrizoate, and ioxitalamate at a ratio of 10% v/v with nonanticoagulated human whole blood was evaluated using the kinetics of fibrinopeptide A (FpA) generation. Blood aliquots were taken every 2 minutes until blood clot occurred. Two groups of contrast media were identified: (1) iohexol and iopamidol, which increased the clotting time, and (2) ioxaglate, diatrizoate, and ioxitalamate, for which all clotting times were over 30 minutes and no FpA generation occurred.
Corot
C
C
Inserm U37, Bron, France.
Perrin
J M
JM
Belleville
J
J
Amiel
M
M
Eloy
R
R
D001777:Blood Coagulation / Q000187:drug effects*; D003287:Contrast Media / Q000494:pharmacology*; D005344:Fibrinopeptide A / Q000032:analysis; D006801:Humans; D066298:In Vitro Techniques; D007458:Iodipamide / Q000031:analogs & derivatives / Q000494:pharmacology; D007472:Iohexol / Q000494:pharmacology; D007479:Iopamidol / Q000494:pharmacology; D007483:Iothalamic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D007485:Ioxaglic Acid / Q000494:pharmacology; D009994:Osmolar Concentration
D003287:Contrast Media; D007483:Iothalamic Acid; D005344:Fibrinopeptide A; D007472:Iohexol; C002587:ioxitalamic acid; D007479:Iopamidol; D007458:Iodipamide; C006753:meglumine iodipamide; D007485:Ioxaglic Acid